Aphria, which trades as APHA on both the New York Stock Exchange and the Toronto Stock Exchange, consistently rejected Green Growth’s offer.
For more details on the offer’s expiration, click here.
Green Growth offer for Aphria cannabis group expires
Latest Headlines
- Tribes in two states considering cannabis opportunities
- Missouri licenses 192 medical marijuana dispensaries
- Alaska licenses state-approved social cannabis consumption
- California to require marijuana retailers to exhibit QR code
- 9,000 vape cartridges recalled from Detroit medical cannabis store
- BC’s adult-use cannabis sales spike in November to pace Canadian growth
- Aphria secures CA$100 million injection from anonymous investor
- No edibles under New Zealand’s medical cannabis scheme, government says
- Report: Thailand issues 442 medical cannabis licenses, but full market access years away
- German pharmacies have new pharmaceutical CBD supplier
Business can expect new markets, fresh opportunities - and more pitfalls.
Aphria is a legal cannabis company in a country where cannabis is actually legal, unlike in the USA.
Aphria could never accept an offer from a company operating on the wrong side of the law. Their Canadian investors would not stand for it.